Replies to post #3576 on Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

Hcomb,

Without Fluticare approval, could you explain how INNV could get nasdaq, AMEX, or nyse listed? Please refer to links below for requirements:

https://listingcenter.nasdaq.com/assets/initialguide.pdf

For one thing $15M in revenues is not enough to get the stock up to a min stock price. Therefore a reverse split. But there is more if you look at the link.

Listing on the nyse without Fluticare? See link below for requirements:

http://finance.zacks.com/minimum-stock-price-nyse-5116.html

The nyse appears to be more attainable. However, again there is a min stock price and without Fluticare, I don't see that being achieved without a RS.

AMEX listing requirements below:

http://www.ehow.com/list_5904003_amex-listing-requirements.html

Now this would be the easiest to achieve but requires a $3 minimum stock price. Again, I don't see this happening withour Fluticare and with even $15M in revenues or a RS is required.